Enrica Capelletto

4PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 18, 2023
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial.

Francesco Passiglia, Luisella Righi, Paolo Bironzo

|Mar 14, 2022
Single agent VS-6766 or VS-6766 plus defactinib in KRAS-mutant non-small-cell lung cancer: the RAMP-202 phase II trial.

Enrica Capelletto, Paolo Bironzo, Louis Denis

|Aug 17, 2019
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial.

Lorenza Landi, Rita Chiari, Marcello Tiseo

|May 04, 2017
Final data of an Italian multicentric survey about counseling for smoking cessation in patients with diagnosis of a respiratory disease.

Enrica Capelletto, Simonetta Grazia Rapetti, Sara Demichelis

Pageof 1